Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens

Wei Zhen, Ryhana Manji, Elizabeth Smith, Gregory J. Berry
doi: https://doi.org/10.1101/2020.04.17.20069864
Wei Zhen
1Infectious Disease Diagnostics, Northwell Health Laboratories, Lake Success, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryhana Manji
1Infectious Disease Diagnostics, Northwell Health Laboratories, Lake Success, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Smith
1Infectious Disease Diagnostics, Northwell Health Laboratories, Lake Success, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory J. Berry
1Infectious Disease Diagnostics, Northwell Health Laboratories, Lake Success, NY
2Department of Pathology and Laboratory Medicine, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gberry1@northwell.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The novel human coronavirus SARS-CoV-2 was first discovered in the city of Wuhan, Hubei province, China, causing an outbreak of pneumonia in January 2020. As of April 10, 2020, the virus has rapidly disseminated to over 200 countries and territories, causing more than 1.6 million confirmed cases of COVID-19 and 97,000 deaths worldwide. The clinical presentation of COVID-19 is fairly non-specific, and symptoms overlap with other seasonal respiratory infections concurrently circulating in the population. Further, it is estimated that up to 80% of infected individuals experience mild symptoms or are asymptomatic, confounding efforts to reliably diagnose COVID-19 empirically. To support infection control measures, there is an urgent need for rapid and accurate molecular diagnostics to identify COVID-19 positive patients. In the present study, we have evaluated the analytical sensitivity and clinical performance of four SARS-CoV-2 molecular diagnostic assays granted Emergency Use Authorization by the FDA using nasopharyngeal swabs from symptomatic patients. This information is crucial for both laboratories and clinical teams, as decisions on which testing platform to implement are made.

Competing Interest Statement

Gregory Berry has previously given education seminars for Hologic, Inc., and received an Honorarium

Funding Statement

We would also like to thank Diasorin Molecular LLC. for providing the reagents used in this study

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

numbers from raw data are summarized in the manuscript to determine LoD, sensitivity, specificity, etc.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 22, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens
Wei Zhen, Ryhana Manji, Elizabeth Smith, Gregory J. Berry
medRxiv 2020.04.17.20069864; doi: https://doi.org/10.1101/2020.04.17.20069864
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens
Wei Zhen, Ryhana Manji, Elizabeth Smith, Gregory J. Berry
medRxiv 2020.04.17.20069864; doi: https://doi.org/10.1101/2020.04.17.20069864

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (75)
  • Allergy and Immunology (194)
  • Anesthesia (54)
  • Cardiovascular Medicine (488)
  • Dentistry and Oral Medicine (89)
  • Dermatology (56)
  • Emergency Medicine (168)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
  • Epidemiology (5649)
  • Forensic Medicine (3)
  • Gastroenterology (215)
  • Genetic and Genomic Medicine (855)
  • Geriatric Medicine (87)
  • Health Economics (229)
  • Health Informatics (756)
  • Health Policy (385)
  • Health Systems and Quality Improvement (250)
  • Hematology (105)
  • HIV/AIDS (181)
  • Infectious Diseases (except HIV/AIDS) (6439)
  • Intensive Care and Critical Care Medicine (387)
  • Medical Education (116)
  • Medical Ethics (28)
  • Nephrology (90)
  • Neurology (844)
  • Nursing (44)
  • Nutrition (141)
  • Obstetrics and Gynecology (161)
  • Occupational and Environmental Health (256)
  • Oncology (514)
  • Ophthalmology (162)
  • Orthopedics (44)
  • Otolaryngology (105)
  • Pain Medicine (45)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (247)
  • Pharmacology and Therapeutics (146)
  • Primary Care Research (112)
  • Psychiatry and Clinical Psychology (958)
  • Public and Global Health (2217)
  • Radiology and Imaging (374)
  • Rehabilitation Medicine and Physical Therapy (171)
  • Respiratory Medicine (310)
  • Rheumatology (109)
  • Sexual and Reproductive Health (80)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)